Cardinal Health reported fourth quarter EPS of $2.60, $0.19 better than the analyst estimate of $2.41. Revenue for the quarter came in at $63.7B versus the consensus estimate of $65.22B.
August 11, 2026 - 15:01
By Pharos Investment Advisors Comments are Off
Cardinal Health reported fourth quarter EPS of $2.60, $0.19 better than the analyst estimate of $2.41. Revenue for the quarter came in at $63.7B versus the consensus estimate of $65.22B.
April 22, 2024 - 14:21
By Pharos Investment Advisors Comments are Off
Shares of Cardinal Health were falling after the drug maker said it won’t be renewing a distribution contract with pharmacy benefits manager OptumRx.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved